Hoag Memorial selected as trial site for promising COVID-19 vaccine

She didn’t really peek as the short needle sunk into her arm. It pinched a little, sure, but avoided the muscle, so didn’t pack the punch of a flu shot. And just like that, recent UC Irvine graduate Chen Cao became the first of 35 people to be vaccinated in NantKwest Inc. and ImmunityBio’s phase 1 clinical trial for COVID-19, happening only at Hoag Memorial Hospital Presbyterian in Newport Beach. “I want to do something good,” Cao, 25, said Wednesday, Oct. 21.